Anti-CD47 monoclonal antibody can inhibit the immune escape of AML leukemic stem cells to macrophages and play an antileukemic role by phagocytosis of leukemic stem cells through macrophages (Majeti et al., 2009). This evidence concerns the gene CD47 and acute myeloid leukemia.